Send us a text Today we get to hear about what experts in pharmaceutical technologies are doing in nanotechnology. We chat about the difference between lipophilic delivery and drug delivery. Victor Francis from DIVERSA gives us a really solid breakdown of the differences and what DIVERSA does with different types of drugs and their work with companies in the early stages of drug discovery. DIVERSA is going to be one of our Innovation Ave NEW companies at SLAS2022 in Boston, MA, USA in February 2...
Jan 03, 2022•20 min•Ep. 96
Send us a text Colleen Janczak from Scintillation Nanotechnologies talked with us today about the really neat work they are doing to make nano-material detectors for radio isotopes. Their vision is to bring previously unheard-of measurement capabilities to radioisotope detection, enabling researchers across the full range of scientific endeavors to ask and answer previously impossible research questions. This episodes breaks down the cool uses of radioisotopes in our community. We learned the mo...
Dec 10, 2021•21 min•Ep. 95
Send us a text Julio Martin , SLAS European Ambassador, joins us again to co-host as we talk to Winston Chiu. Winston is an amazing young scientists who is a PhD student at KU Keuven in Belgium. Winston walks us through his research into highly infectious diseases, his adventures in robotic programming (and the accidents that happened along the way), and his viewpoint on life and learning. Winston was a poster presenter at SLAS Europe 2021, a SLAS Student Poster Award Winner, and is an Expert Op...
Nov 29, 2021•20 min•Ep. 94
Send us a text Today we hear Lillie Bell , who is studying BSc Medical Biochemistry at the University of Leeds . Lillie in particular has been looking at target and protein degradation as she was recently she was a Undergraduate Industrial Placement Student in the highthrouput screening group at AstraZeneca . She is really excited that some of the work she did while AstraZeneca will be used for novel chemistry. Tune in for all the details! Lillie was a poster presenter and Student Poster Award W...
Oct 25, 2021•11 min•Ep. 93
Send us a text Today we are chatting with members of the AI Powered Drug Discovery Symposium planning committee; Fernanda Duarte and Kurt Anderson . We are really excited about this hybrid symposium coming up in early November in London. The event has a really amazing line up of speakers as we explore the latest research on data-driven discovery. In addition to the traditional topics surrounding AI Powered Drug Discovery, speakers will also dive into the ethical questions surrounding it. Listen ...
Oct 18, 2021•12 min•Ep. 92
Send us a text How do we combine physics and engineering with biomedical research to develop technological solutions for accelerating the human disease knowledge? What cool new technologies are there to discover these solutions to improve the quality of patient life? Well, Silvia Scaglione from React4Life joins us today to share their deeply innovative and highly reactive work. Dive in with us today to find out more! Silvia Scaglione , President and Chief Scientific Officer from React4Life which...
Oct 11, 2021•12 min•Ep. 91
Send us a text Start By Listening. Sound advice from Amel Bendali of start-up Inorevia . She, and her fellow Co-founder, listened to what scientists in the field needed and decided to take the next step in lab automation by miniaturizing their processes. Hear how Inorevia is making things smaller, faster, and smarter as Amel Bendali talks with SLAS Program Manager Liz Frank, and co-host Julio Martin on the latest episode. Amel Bendali is COO & co-Founder of Inorevia , an Innovation Ave NEW c...
Oct 04, 2021•18 min•Ep. 90
Send us a text Is it possible for the body's own immune system to fight of cancer? It could be. This is what Stephan Spangenberg and his colleagues at Scripps Research Institute are trying to figure out. Colin Cox from Seer sits in today as co-host with Liz as they chat with Stephan about the ins and outs of his research, his student poster award win, and his excitement over publishing his first research paper. Stephan Spangenberg is Graduate Student at the Scripps Research Institute. He wa...
Sep 27, 2021•19 min•Ep. 89
Send us a text Working in 3D systems can be challenging, and the presentations at the upcoming Building Biology in 3D Symposium will provide researchers with a swiss army knife of tools to improve their work. Listen in as members of the program committee share their excitement around the sessions, keynotes, and collaborative potential. A special thanks to Brinton Seashore-Ludlow , Sinead Knight , Herve Tiriac , Ross Lagoy , Glauco Souza , and Marc Bickle for sitting down and talking to us about ...
Sep 20, 2021•14 min•Ep. 88
Send us a text Manuela Beil-Peter (Analytik Jena GmbH) and Clive Green (AstraZeneca) sit down with Liz to share how the program of the European Sample Management (ESM) Symposium will explore this mature discipline and the evolutions and advancements that have taken place in the last few years. Listen in to find out how we plan to energize the community and prove that the future is bright! The European Sample Management Symposium will take place in Berlin, Germany October4-5, 2021 . This hybrid e...
Sep 13, 2021•16 min•Ep. 87
Send us a text A meta-roboticist, a theoretical physical inorganic chemist, and an automated science educator sit down for a podcast.... Join us today as guest host Mike Tarselli talks with Jason Hein, Joshua Schrier, and Josh Kangas about the AI automation explosion. Where have we come from and where are we now? Where are we going and what are we doing to placate our pending robot overlords? Let's find out together. If you want to learn more about what Mike, Jason, Joshua, and Josh work on...
Sep 06, 2021•34 min•Ep. 86
Send us a text How does cancer develop, grow, and how can we treat it? Where are we at in developing personalized cancer treatments? These the questions Pilar Ayuda-Durán has been trying to answer in her research into unraveling cancer biology and designing new treatments against the disease. Our guest host, Brinton Seashore-Ludlow gets a sneak peek into Pilar's current research and her excitement over the initial results. In addition to the serious stuff, the conversation took a fun spin i...
Aug 30, 2021•14 min•Ep. 85
Send us a text Members of the Americas Sample Management Symposium Program Committee joined us today to talk about the importance of this small but strong community and their excitement over the symposium in just a few weeks. Listen in as the ladies share with us why it is so important this community gathers together this fall, what sessions they are most excited about, and what the icing on the cake at the symposium will be. And if the scientific content isn't enough, this is also a loving...
Aug 19, 2021•15 min•Ep. 84
Send us a text Why are 3D cell cultures so exciting? What IS the difference between a 2D and 3D cell culture? Experts from Corning ; Audrey Bergeron , Claire (Linyu) Zhang, and Alejandro Montoya joined Marshall to explain the new applications of 3D cell cultures and what considerations need to be taken into account when working within these new models. If you are looking to transition to using 3D cell cultures, this episode outlines exactly what tools and training you will need to do so. Corning...
Jun 11, 2021•31 min•Ep. 83
Send us a text Steve Swioklo visits New Matter this week to share with us how Atelerix technology provides an innovative solution for storing and transporting cells and tissues at room temperature and in a balanced state. Steve also gives good advice on the transition between academia and a startup. Join us in learning more about this Innovation Ave NEW company and where they want to go next. Upcoming SLAS Events: SLAS Europe 2025 Conference and Exhibition 20-22 May 2025 Hamburg, Germany View th...
May 24, 2021•19 min•Ep. 82
Send us a text Join Ross Lagoy and Marshall discussing CRISPR/Cas9 genome editing, developing critical platform technologies that accelerate drug discovery and how to connect the bench to automation. Ross is a Senior Scientist at Intellia Therapeutics working to establishing new technologies and analysis pipelines to help identify potential cures for patients living with genetic disease. Upcoming SLAS Events: SLAS Europe 2025 Conference and Exhibition 20-22 May 2025 Hamburg, Germany View the ful...
May 10, 2021•16 min•Ep. 81
Send us a text On this episode we discuss the importance of bio convergence and how CELLINK Is looking at all the areas that lead to greater discovery in biology. Paul Berning shares with us their excitement at the development of an automation system designed to minimize labor-intensive processes and maximize efficiency within cell line development. As so many companies have, CELLINK had to pivot their work with the onset of the pandemic, and they are proud of how they developed successful solut...
Apr 29, 2021•15 min•Ep. 80
Send us a text Continuing on with the discussion on drug resistance in cancer treatment Ming Yao joins Marshall to share the tissue culture device that he helped to develop to better study drug response to tumor cells. With an engineering background, when Ming started his graduate degree he had to take a crash course in biology and cell culture, which caused him to fall in love with science. Future researchers, keep an eye out for Ming, one day he'll be running his own lab and will need res...
Apr 27, 2021•15 min•Ep. 79
Send us a text Did you know that Montreal has the second largest population of PhDs in the world? No? Well this Montreal startup is inspired by the innovations brought forth in the city. CEO of Ananda Devices Margaret Magdesian 's goal is to automate neuronal testing and accelerate the development of new compounds and to reduce use of animals by 90%. Ananda Devices is a biotech company offering proprietary high throughput cellular and tissue nano-organization technology to accelerate R&...
Apr 19, 2021•16 min•Ep. 78
Send us a text SLAS recently brought Raven Solomon (a global Diversity, Equity, and Inclusion thought leader) in to talk to the professional team about unconscious bias. She made such a huge impact on us that we had to bring her in to talk again to our broader New Matter audience. Raven talks to Marshall and returning guest host Karlton Moore about helping organizations get future ready by understanding generational and racial equity. They discuss the need to make spaces more equitable and more ...
Apr 12, 2021•44 min•Ep. 77
Send us a text Sebastien Mosser comes to us to tell us how Neurix SA is working to reduce animal and animal tissue use in scientific research. Neurix is creating organoids that simulate brain tissue for compound screening and neuroscience research. Sebastian describes how they adapted their techniques and their platform to help with COVID-19 related tests. Neurix SA was a Innovation Ave NEW company at SLAS2021 Digital. Upcoming SLAS Events: SLAS Europe 2025 Conference and Exhibition 20-22 May 20...
Apr 07, 2021•13 min•Ep. 76
Send us a text Stefan Schneider is engaged in the development and application of novel organ-on-a-chip systems, a relatively novel and exciting research focus. He shares with Marshall the enabling advances that allowed him to accomplish this work. What is the most exciting application of organ on a chip? Listen and find out! Stefan is a Tony B. Awardee and Innovation Award Finalist from SLAS2021 Digital. Upcoming SLAS Events: SLAS Europe 2025 Conference and Exhibition 20-22 May 2025 Hamburg, Ger...
Apr 05, 2021•14 min•Ep. 75
Send us a text What is the difference between ThermoFRET and BRET-Based techniques? David Sykes (The University of Nottingham) provides us with a cheat sheet for which problems these techniques are best suited. Listen in as his passion for discovery and solving problems (and his stimulating work with Sir James Black ) steers his career path forward. David is an SLAS2021 Digital Tony B. Award and Student Poster Award Winner . Upcoming SLAS Events: SLAS Europe 2025 Conference and Exhibition 20-22 ...
Mar 31, 2021•13 min•Ep. 74
Send us a text Why it is important to be curious for the sake of curiosity? Pouria Rafsanjani Nejad (University of Akron) tells us what he thinks. He talks to Marshall about the problems with cancer therapeutics, and how to cure patients without causing bigger problems along the way. Follow him along his path from building model cars to reframing the problem of biology for himself through the study of biomedical engineering. And as Marshall states so adamantly, SLAS lives for the nerds like Pour...
Mar 29, 2021•13 min•Ep. 73
Send us a text Claudio Rolli visits today from FLUICS GmbH which is working on sustainable sample tracking for research labs. They have developed an online label maker and its correlating mobile app which turns your mobile device or tablet into a barcode scanner and label maker that are directly connected to an online inventory database. Claudio and his co-founders want to eliminate the traditional personal frustrations in labs, such as searching for samples, trying to maintain uncountable excel...
Mar 24, 2021•15 min•Ep. 72
Send us a text Astha Lamichhane is a Tony B. Awardee from SLAS2021 Digital and is researching the underlying reasons for why some drugs work on cancer treatment some don't. What is it about a persons individual genomes that resist some treatments, and how can we solve that at the cellular level? Hear about Astha's most exciting professional accomplishment and where she wants to go once she has finished her degree. Upcoming SLAS Events: SLAS Europe 2025 Conference and Exhibition 20-22 M...
Mar 22, 2021•13 min•Ep. 71
Send us a text Kilobaser GmbH has developed a microfluidics based and cartridge based DNA synthesizer. It is designed to let researchers synthesize DNA right in the lab. Think about it like being able to make your favourite espresso right in house instead of running to the barista down the street. So, what is so special about their synthesizer? Alexander Murer joins us to share exactly what. Listen in to find out! Kilobaser GmbH was a Innovation Ave NEW company at SLAS2021 Digital. Upcoming SLAS...
Mar 17, 2021•17 min•Ep. 70
Send us a text LabVoice connects the scientist to the lab through voice assistance. This is not just an Alexa for the lab, it is much more than that! Hear Dan DeAlmeida explain the secret sauce of how LabVoice integrates with your existing lab infrastructure and helps you execute your tasks. LabVoice was a Innovation Ave NEW company at SLAS2021 Digital. Upcoming SLAS Events: SLAS Europe 2025 Conference and Exhibition 20-22 May 2025 Hamburg, Germany View the full events calendar...
Mar 15, 2021•17 min•Ep. 69
Send us a text Evan Hegarty started out in helping human disease in Alzheimer's and moved his way up to co-found Newormics . Newormics offers toxicology services using their advanced microfluidic devices for high-throughput and high-content screening of small animal models and 3D tissue organoids. Evan talks about their exciting new project in testing a full chemical library of known toxicities from the NIH. Their goal is to reduce animal testing by using their technology, which will be a h...
Mar 10, 2021•14 min•Ep. 68
Send us a text Jens Schwamborn and his company OrganoTherapeutics is using their technology (human-specific mini-brains) to treat Parkinson's. He walks Marshall through how they grew their young company through the time of a global pandemic and the opportunities they made from it to use their technology to support research in therapies related to SARS COV 2. OrganoTherapuetics is a SLAS2021 New Product Award winner and an participated in Innovation Ave NEW at SLAS2021 Digital. Upcoming SLAS...
Mar 08, 2021•8 min•Ep. 67
